Render Target: SSR
Render Timestamp: 2024-08-29T22:10:16.291Z
Commit: 419142f0105700b709b94a8ebde4734bae2c62a3
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77

ETAA1 (E8U8B) Rabbit mAb #77021

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 120
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:100

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    ETAA1 (E8U8B) Rabbit mAb recognizes endogenous levels of total ETAA1 protein.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Lys406 of human ETAA1 protein.

    Background

    Ataxia telangiectasia and Rad3-related (ATR) is an essential kinase with functions in DNA damage and the replication stress response, as well as in maintaining chromosome stability during mitosis (1,2). ATR is activated in mammalian cells by TopBP1 (3) or Ewing's tumor-associated antigen 1 (ETAA1) (4). ETAA1 binds to RPA-coated single-stranded DNA at stalled replication forks, activating ATR signaling independently of TopBP1 in response to replication stress, protecting replication fork integrity (4-6). ATR activation by ETAA1 is required for T cell clonal expansion in mice (7). Quantitative phosphoproteomics demonstrates a dominant role for ETAA1 in mitotic ATR activation (8).

    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.